Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients

Journal of Clinical Virology

Volumn 58, Issue 4, 2013, Pages 629-634

  Pas, Suzan D ^a   Streefkerk, Roel H R A ^a   Pronk, Mark ^a   de Man, Robert A ^a   Beersma, Matthias F ^a   Osterhaus, Albert D M E ^a   Van der Eijk, Annemiek A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diagnostics; ELISA; Hepatitis E virus; Immune response; Immunocompromised; Transplantation

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGENICITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

AREA UNDER THE CURVE; AUC; CMV; CYTOMEGALOVIRUS; DIAGNOSTICS; EBV; ELISA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS; HAV; HBV; HCV; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HEV; IMMUNE RESPONSE; IMMUNOCOMPROMISED; LABORATORY INFORMATION MANAGEMENT SYSTEM; LIMS; OD; OPEN READING FRAME; OPTICAL DENSITY; ORF; RECEIVER OPERATOR CURVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEIC ACID; RNA; ROC; RT-PCR; S/N; SIGNAL TO NOISE; TRANSPLANTATION; WHO; WORLD HEALTH ORGANIZATION;

ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84888828750     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.10.010     Document Type: Article

References (21)

1. Dalton H.R., Bendall R., Ijaz S., Banks M., Hepatitis E. an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
2. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009, 24:1484-1493.
3. Koning L., Pas S.D., de Man R.A., Balk A.H., de Knegt R.J., ten Kate F.J., et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant Off Pub Int Soc Heart Transplant 2013, 32:78-85.
4. Huang S., Zhang X., Jiang H., Yan Q., Ai X., Wang Y., et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One 2010, 5:e13560.
5. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010, 202:835-844.
6. Pas S.D., de Man R.A., Mulders C., Balk A.H., van Hal P.T., Weimar W., et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012, 18:869-872.
7. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010, 82:799-805.
8. Herremans M., Bakker J., Duizer E., Vennema H., Koopmans M.P. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 2007, 14:562-568.
9. Wang Y., Zhang H., Li Z., Gu W., Lan H., Hao W., et al. Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4. J Clin Microbiol 2001, 39:4370-4379.
10. Drobeniuc J., Meng J., Reuter G., Greene-Montfort T., Khudyakova N., Dimitrova Z., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
11. Li T.C., Yamakawa Y., Suzuki K., Tatsumi M., Razak M.A., Uchida T., et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997, 71:7207-7213.
12. Legrand-Abravanel F., Thevenet I., Mansuy J.M., Saune K., Vischi F., Peron J.M., et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009, 16:772-774.
13. Wenzel J.J., Preiss J., Schemmerer M., Huber B., Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013, 207:497-500.
14. Abravanel F., Mansuy J.-M., Huynh A., Kamar N., Alric L., Peron J.-M., et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012, 54:152-155.
15. Park H.K., Jeong S.H., Kim J.W., Woo B.H., Lee D.H., Kim H.Y., et al. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis 2012, 12:142.
16. Schnegg A., Burgisser P., Andre C., Kenfak-Foguena A., Canellini G., Moradpour D., et al. An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. PLoS One 2013, 8:e62980.
17. Ferguson M., Walker D., Mast E., Fields H. Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biol J Int Assoc Biol Standard 2002, 30:43-48.
18. Khudyakov Y., Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res 2011, 161:84-92.
19. Zhang J., Li S.W., Wu T., Zhao Q., Ng M.H., Xia N.S. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Rev Med Virol 2012, 22:339-349.
20. Edwards R. Immuno-diagnostiscs. A practical approach 1999, Oxford University, Oxford.
21. Ruth C., Matthews J.P.B. Handbook of serodiagnosis in infectious diseases 1991, Butterworth-Heinemann, London.